Alnylam Pharmaceuticals
ALNY
ALNY
193 hedge funds and large institutions have $3.68B invested in Alnylam Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 75 increasing their positions, 68 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $37.3M | Put options by funds: $41.7M
12% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 34
Holders
193
Holding in Top 10
3
Calls
$37.3M
Puts
$41.7M
Top Buyers
| 1 | +$110M | |
| 2 | +$68.7M | |
| 3 | +$39.3M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$38M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.6M |
Top Sellers
| 1 | -$57M | |
| 2 | -$22.6M | |
| 3 | -$21.6M | |
| 4 |
CCI
Columbus Circle Investors
|
-$17.9M |
| 5 |
DM
Deerfield Management
New York
|
-$12.8M |